These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19331415)

  • 1. Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.
    Ulens C; Akdemir A; Jongejan A; van Elk R; Bertrand S; Perrakis A; Leurs R; Smit AB; Sixma TK; Bertrand D; de Esch IJ
    J Med Chem; 2009 Apr; 52(8):2372-83. PubMed ID: 19331415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine binding protein (AChBP) as template for hierarchical in silico screening procedures to identify structurally novel ligands for the nicotinic receptors.
    Akdemir A; Rucktooa P; Jongejan A; Elk Rv; Bertrand S; Sixma TK; Bertrand D; Smit AB; Leurs R; de Graaf C; de Esch IJ
    Bioorg Med Chem; 2011 Oct; 19(20):6107-19. PubMed ID: 21920761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates.
    Yamauchi JG; Gomez K; Grimster N; Dufouil M; Nemecz A; Fotsing JR; Ho KY; Talley TT; Sharpless KB; Fokin VV; Taylor P
    Mol Pharmacol; 2012 Oct; 82(4):687-99. PubMed ID: 22784805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
    Xiao Y; Hammond PS; Mazurov AA; Yohannes D
    J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel α7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric α7 receptor ligand binding domain.
    Akdemir A; Edink E; Thompson AJ; Lummis SC; Kooistra AJ; de Graaf C; de Esch IJ
    Bioorg Med Chem; 2012 Oct; 20(19):5992-6002. PubMed ID: 22959526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
    Hansen SB; Taylor P
    J Mol Biol; 2007 Jun; 369(4):895-901. PubMed ID: 17481657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties.
    Zouridakis M; Zisimopoulou P; Eliopoulos E; Poulas K; Tzartos SJ
    Biochim Biophys Acta; 2009 Feb; 1794(2):355-66. PubMed ID: 19059502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
    Tsetlin V; Utkin Y; Kasheverov I
    Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
    Hansen SB; Sulzenbacher G; Huxford T; Marchot P; Taylor P; Bourne Y
    EMBO J; 2005 Oct; 24(20):3635-46. PubMed ID: 16193063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor.
    Brejc K; van Dijk WJ; Smit AB; Sixma TK
    Novartis Found Symp; 2002; 245():22-9; discussion 29-32, 165-8. PubMed ID: 12027010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism.
    Bourne Y; Radic Z; Aráoz R; Talley TT; Benoit E; Servent D; Taylor P; Molgó J; Marchot P
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6076-81. PubMed ID: 20224036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of Lymnaea stagnalis AChBP complexed with the potent nAChR antagonist DHβE suggests a unique mode of antagonism.
    Shahsavar A; Kastrup JS; Nielsen EØ; Kristensen JL; Gajhede M; Balle T
    PLoS One; 2012; 7(8):e40757. PubMed ID: 22927902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of agonists versus antagonists of nicotinic ligands based on docking onto AChBP structures.
    Taly A; Colas C; Malliavin T; Blondel A; Nilges M; Corringer PJ; Joseph D
    J Mol Graph Model; 2011 Sep; 30():100-9. PubMed ID: 21764343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists.
    Arunrungvichian K; Fokin VV; Vajragupta O; Taylor P
    ACS Chem Neurosci; 2015 Aug; 6(8):1317-30. PubMed ID: 25932897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors.
    Talley TT; Olivera BM; Han KH; Christensen SB; Dowell C; Tsigelny I; Ho KY; Taylor P; McIntosh JM
    J Biol Chem; 2006 Aug; 281(34):24678-86. PubMed ID: 16803900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted 2-Aminopyrimidines Selective for α7-Nicotinic Acetylcholine Receptor Activation and Association with Acetylcholine Binding Proteins.
    Kaczanowska K; Camacho Hernandez GA; Bendiks L; Kohs L; Cornejo-Bravo JM; Harel M; Finn MG; Taylor P
    J Am Chem Soc; 2017 Mar; 139(10):3676-3684. PubMed ID: 28221788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding orientation of epibatidine at α7 nACh receptors.
    Thompson AJ; Metzger S; Lochner M; Ruepp MD
    Neuropharmacology; 2017 Apr; 116():421-428. PubMed ID: 28089847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptor.
    Spurny R; Debaveye S; Farinha A; Veys K; Vos AM; Gossas T; Atack J; Bertrand S; Bertrand D; Danielson UH; Tresadern G; Ulens C
    Proc Natl Acad Sci U S A; 2015 May; 112(19):E2543-52. PubMed ID: 25918415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
    Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
    Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.